16002 Federal Register / Vol. 87, No. 54 / Monday, March 21, 2022 / Notices 

Name of Committee: Safety and 

Occupational Health Study Section 

(SOHSS), National Institute for 

Occupational Safety and Health 

(NIOSH). 

Dates: June 14–15, 2022. 

Times: 11:00 a.m.–5:00 p.m., EDT. 

Place: Teleconference. 

Agenda: The meeting will convene to 

address matters related to the conduct of 

Study Section business and for the 

study section to consider safety and 

occupational health-related grant 

applications. 

FOR FURTHER INFORMATION CONTACT: 

Michael Goldcamp, Ph.D., Scientific 

Review Officer, NIOSH, 1095 

Willowdale Road, Morgantown, West 

Virginia 26506, Telephone: (304) 285– 

5951; Email: mgoldcamp@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–05802 Filed 3–18–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Board on Radiation and 

Worker Health (ABRWH), National 

Institute for Occupational Safety and 

Health (NIOSH) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting and request 

for comment. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

of the Advisory Board on Radiation and 

Worker Health (ABRWH or the Advisory 

Board). This meeting is open to the 

public, limited only by the number of 

audio conference lines and internet 

conference accesses available, which is 

200 combined. The public is welcome to 

submit written comments in advance of 

the meeting, to the contact person 

below. Written comments received in 

advance of the meeting will be included 

in the official record of the meeting. The 

public is also welcome to listen to the 

meeting by joining a teleconference line 

and/or computer connection 

(information below). 

DATES: The meeting will be held on 

April 27, 2022, from 1:00 p.m. to 6:00 

p.m., EDT, and April 28, 2022, from 

1:00 p.m. to 4:00 p.m., EDT. A public 

comment session will be held on April 

27, 2022, at 5:00 p.m., EDT, and will 

conclude at 6:00 p.m., EDT, or following 

the final call for public comment, 

whichever comes first. 

Written comments must be received 

on or before April 20, 2022. 

ADDRESSES: You may submit comments 

by mail to: Sherri Diana, National 

Institute for Occupational Safety and 

Health, 1090 Tusculum Avenue, MS C– 

34, Cincinnati, Ohio 45226. 

Meeting Information: The USA tollfree dial-in numbers are: +1 669 254 

5252 US (San Jose); +1 646 828 7666 US 

(New York); +1 551 285 1373 US; +1 

669 216 1590 US (San Jose); The 

Meeting ID is: 160 6763 3819 and the 

Passcode is: 98685439; Web conference 

by Zoom meeting connection: https://

cdc.zoomgov.com/j/16067633819?

pwd=RUdiYXlZZHFK

anpJOHZrcGJIbTlaZz09. 

FOR FURTHER INFORMATION CONTACT: 

Rashaun Roberts, Ph.D., Designated 

Federal Officer, NIOSH, CDC, 1090 

Tusculum Avenue, Mailstop C–24, 

Cincinnati, Ohio 45226, Telephone: 

(513) 533–6800, Email: ocas@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines 

which have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule, advice on 

methods of dose reconstruction which 

have also been promulgated by HHS as 

a final rule, advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program, and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort (SEC). In 

December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, 

which subsequently delegated this 

authority to the CDC. NIOSH 

implements this responsibility for CDC. 

The Advisory Board’s charter was 

issued on August 3, 2001, renewed at 

appropriate intervals, rechartered on 

March 22, 2020, and will terminate on 

March 22, 2022. 

Purpose: This Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advising the Secretary 

on whether there is a class of employees 

at any Department of Energy facility 

who were exposed to radiation but for 

whom it is not feasible to estimate their 

radiation dose, and on whether there is 

reasonable likelihood that such 

radiation doses may have endangered 

the health of members of this class. 

Matters to be Considered: The agenda 

will include discussions on the 

following: NIOSH Program Update; 

Department of Labor Program Update; 

Department of Energy Program Update; 

SEC Petitions Update; Procedures 

Review Finalization/Document 

Approvals; Update on Review of SEC– 

00253 Petition Evaluation Report for 

Reduction Pilot Plant; Update on 

Review of SEC–00188 Sandia Petition 

Addendum 2; Subcommittee on Dose 

Reconstruction Reviews Update; and a 

Board Work Session. Agenda items are 

subject to change as priorities dictate. 

For additional information, please 

contact Toll Free 1 (800) CDC–INFO. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–05800 Filed 3–18–22; 8:45 am] 

BILLING CODE 4163–18–P 


khammond on DSKJM1Z7X2PROD with NOTICES